Reference number : 276-2010-2011-Q4-00274, amendment number : , agreement type : C, recipient legal name : Lisi Therapeutics Inc.|Lisi Therapeutics Inc., recipient country : CA, recipient province : ON, recipient city : Charlottetown|Charlottetown, recipient postal code : C0A 1P0, program name english : Atlantic Innovation Fund (AIF) - II, program name french : Fonds d'innovation de l'Atlantique (FIA) - II, program purpose english : nan, program purpose french : nan, agreement title english : 195196, agreement title french : 195196, agreement number : 195196, agreement value : 1920000.0, agreement start date : 2011-03-03, agreement end date : 2012-12-31, description english : Development of an innovative advanced cancer drug therapy, description french : Dév. une pharmacothérap. de pointe novatr. contre cancer, expected results english : nan, expected results french : nan, additional information english : The assistance type is Conditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement conditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique